Post Profile

Promising Ebola Drug ZMapp: The Real Lessons of an Inconclusive Study

Rather than providing an answer to whether ZMapp can really cut the risk of death from Ebola, the results of a new study are inconclusive.
read more


Related Posts

ZMapp, the experimental Ebola drug, falls short in clinical trial that couldn't find enough new patients

Academics : LA Times: Science

ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the experimental medication were helped by it. Among 36 patients who were randomly assign...

Study finds Ebola treatment ZMapp holds promise, although results not definitive

Health / Diseases & Conditions : EurekAlert: Diseases

(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial to evaluate the experimental Ebola treatment ZMapp found it to be safe and well-tolerated; however, because of the waning Ebola epidemic, the study enrolle...

Ebola Drug 'ZMapp' Saves Infected Monkeys, Study Shows

News : The Newsroom

An experimental drug called ZMapp, which contains a cocktail of three antibodies that fight the Ebola virus, has successfully treated 18 monkeys infected with the deadly disease, researchers reported today. The new results raise hop...

Scientists pinpoint Ebola's weak spots

Academics / General Science : ScienceDaily: Science Society

Scientists have now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus. The new study is also the first to show how an antibody in the ZMapp 'drug cocktail' targets a second Ebola virus pro...

Study: Experimental Ebola drug ZMapp may benefit patients, but insufficient data

Academics / General Science : Science Codex

According to initial results from a randomized, controlled trial of the experimental Ebola treatment ZMapp, the monoclonal antibody cocktail was well-tolerated and showed promise. Due to decreasing incidence in Ebola, the study coul...


Copyright © 2016 Regator, LLC